Isotretinoin prescribing and monitoring practices among Australian dermatologists measured against current guidelines, and identification of practice uncertainties

Nicholas Manuelpillai; Emma Veysey

doi:10.1111/ced.15048

Isotretinoin prescribing and monitoring practices among Australian dermatologists measured against current guidelines, and identification of practice uncertainties

Clin Exp Dermatol. 2022 Apr;47(4):770-773. doi: 10.1111/ced.15048. Epub 2022 Jan 5.

Authors

Nicholas Manuelpillai¹, Emma Veysey²

Affiliations

¹ Skin Health Institute, Melbourne, VIC, Australia.
² Department of Dermatology, St Vincent's Hospital Melbourne, Melbourne, VIC, Australia.

PMID: 34856005
DOI: 10.1111/ced.15048

Abstract

This letter summarizes the outcomes from an anonymous survey conducted among Australian dermatologists. It provides a comparison of Australian isotretinoin prescribing practices against best available evidence and guidelines in the UK, Europe and USA.

Publication types

Letter

MeSH terms

Acne Vulgaris*
Australia
Dermatologists
Humans
Isotretinoin* / therapeutic use
Practice Patterns, Physicians'
Surveys and Questionnaires

Substances

Isotretinoin